The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Metoject 50 mg/ml Solution for Injection, pre-filled syringe

medac Gesellschaft für klinische Spezialpräparate mbHPA0623/014/001

Main Information

Trade NameMetoject 50 mg/ml Solution for Injection, pre-filled syringe
Active SubstancesMethotrexate
Dosage FormSolution for injection in pre-filled syringe
Licence Holdermedac Gesellschaft für klinische Spezialpräparate mbH
Licence NumberPA0623/014/001

Group Information

ATC CodeL04AX Other immunosuppressants
L04AX03 methotrexate


License statusWithdrawn
Withdrawn Date29/05/2024
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back